Abstract：Objective To analyze the results of HIV viral load after receiving antiretroviral therapy and related influencing factors in HIV infectors/AIDS patients (hereinafter to be referred as HIV/AIDS patients) in Shaanxi Province. Methods The viral load of HIV was detected in 1,046 HIV/AIDS patients who underwent antiretroviral therapy for more than six months, and the viral load results and related influencing factors were analyzed combined with their epidemiological data. Results Among the 1,046 HIV/AIDS patients, patients with HIV viral load ≥ 1,000 copies/ml, 50-999 copies/ml and ＜50 copies/ml and patients reported as TND (target not detected) accounted for 9.6% (100/1,046), 9.1% (95/1,046), 25.4% (266/1,046) and 55.9% (585/1,046) respectively. Univariate analysis showed that there were statistically significant differences in the ethnic group (P<0.05), educational background (χ2=10.901, P<0.05), route of infection (χ2=14.286, P<0.05) between the group of HIV viral load < 1,000 copies/ml and the group of HIV viral load ≥ 1,000 copies/ml. Multivariate logistic regression analysis showed that college and above educational background was the protective factor for viral load ≥ 1,000 copies/ml (OR=0.344, 95%CI:0.121-0.979), while injection drug use was the risk factor for viral load ≥1,000 copies/ml (OR=5.237, 95%CI:1.272-21.556). Conclusions Antiretroviral therapy for HIV/AIDS patients in Shaanxi Province is characterized with good clinical effect, but it is still necessary to improve the patients’ treatment compliance and reduce the virus suppression failure.
[1] 茅乃玲, 吴德仁, 郭伟贵, 等. 北海市2010－2013年艾滋病抗病毒治疗CD4+T淋巴细胞计数和HIV病毒载量结果分析[J]. 中华疾病控制杂志, 2015,19(4):424-425,428.
[2] 彭志行, 鲁佳菲, 王岚, 等. 中国艾滋病抗病毒治疗的流行病学研究[J]. 中华流行病学杂志, 2012, 33(9):977-982.
[3] 李燕, 徐慧芳, 韩志刚, 等. CD4+T淋巴细胞增殖与艾滋病疾病进展的关系研究[J]. 中国艾滋病性病, 2013, 19(2):91-95.
[4] 《国家免费艾滋病抗病毒药物治疗手册》编写组, 国家免费艾滋病抗病毒药物治疗手册[M]. 北京:人民卫生出版社,2016:144-149.
[5] 崔倩, 俞文祥, 祁耀,等. 盐城市2005－2015年艾滋病抗病毒治疗患者生存分析 [J]. 实用预防医学, 2018,25(11):538-542.
[6] Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy[J]. N Engl J Med, 2011, 365(6):493-505.
[7] 金玫华, 杨中荣, 董正全, 等. 湖州市艾滋病抗病毒治疗效果分析[J]. 预防医学, 2016,28(10):1019-1020.
[8] 隆素素, 席娜娜, 左宗力, 等. 抗病毒治疗1年后的疗效评价及病毒抑制失败影响因素分析[J]. 中国艾滋病性病, 2015,21(12):1004-1007.
[9] 李叶兰, 黄竹林, 单飞. 2009－2010年长沙市艾滋病抗病毒治疗效果分析[J]. 实用预防医学, 2012,19(11):1740-1741.
[10] 曹咏红, 张勇, 谭毅. 影响艾滋病抗病毒治疗效果有关因素的研究进展[J]. 中国临床新医学, 2013,6(8):822-825.
[11] 田翠翠, 李辉, 肖永康, 等. 艾滋病病人抗病毒治疗服药依从性及相关影响因素[J]. 中国艾滋病性病, 2013,19(5):381-384.
[12] Maqutu D, Zewotir T, North D, et al. Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa:a longitudinal study[J]. AIDS Behav, 2011, 15(7):1465-1474.
[13] Wang X, Yang L, Li H, et al. Factors associated with HIV virologic failure among patients on HAART for one year at three sentinel surveillance sites in China[J]. Curr HIV Res, 2011, 9(2):103-111.
[14] Chesney MA. Factors affecting adherence to antiretroviral therapy[J]. Clin Infect Dis, 2000, 30(Suppl 2):S171-176.
[15] Young J, Scherrer AU, Gunthard HF, et al. Efficacy, tolerability and risk factors for virological failure of darunavir-based therapy for treatment-experienced HIV-infected patients:the Swiss HIV Cohort Study[J]. HIV Med, 2011, 12(5):299-307.
[16] 裴启星,赵希畅,周晓林.上海浦东新区HIV抗体阳性男男性行为者的服药依从性影响因素[J].中国热带医学, 2017,17(11):1111-1114.
[17] 滕涛, 冷雪冰, 梁淑家, 等. 静脉吸毒艾滋病病毒感染者和病人抗病毒治疗后病毒抑制失败及耐药发生原因研究[J]. 中国病毒病杂志, 2016,6(2):94-98.
[18] Zaccarelli M, Barracchini A, Longis PD, et al. Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine[J]. AIDS Patient Care STDS, 2002, 16(2):67-73.
2019, Vol. 26 
